UK Clinical Trials

To date there have been four clinical trials of potential drug treatments for Rett syndrome. Earlier this year, the UK regulator the MHRA approved Clinical Trial Applications from two gene therapy companies to start children’s gene therapy trials in the UK.

There is a lot of work that goes into preparing for these sorts of clinical trials to start. Trial sites have to go through rigorous inspections and review boards. Training and planning has to take place and contracts have to be signed.

Because these sorts of products are also fairly new to health systems and the hospitals where the trials are taking place, the hospitals, doctors, administrators, companies and review boards involved are especially careful to make sure that all standards are met.

If you would like to find out more about the implementation of clinical trials for Rett and what might be happening between authorisations and the initiation of trials, watch our Reverse Rett Emerging Gene Therapies Bitesize session here.

There has never been more potential for disease-modifying treatments for Rett syndrome than there is today.

Current gene therapy programs and those in development have grown out of academic research projects supported by Reverse Rett though our long-standing partnership with the Rett Syndrome Research Trust.

Under-enrolment in clinical trials is one of the biggest challenges for researchers and trial sponsors, and it can slow the development of new treatments. That’s why Reverse Rett developed the Rett Registry UK and Clinical Trial Support Services. The successful implementation of four drug trials demonstrated feasibility for UK clinical trials of gene therapies which have now been approved.

As well as helping to identify patients for clinical trials, the Rett Registry UK is also helping us to identify where there are concentrations of patients with Rett for future delivery of approved treatments.

Having an accurate number of patients with Rett syndrome living in the UK will also enable us to more effectively build the case for support for funding for disease-modifying treatments for everyone with Rett syndrome regardless of age or gender.

The Benefits of Participating in a Clinical Trial

Participating in a clinical trial can be a very satisfying and worthwhile experience. People choose to participate in clinical trials for a number of different reasons, the most obvious being early access to an emerging treatment for a condition for which other treatment options are limited or non-existant.

What about the risks?

Although there are many benefits to participating in a clinical trial, it is important to remember there also are risks. Possible risks include: – Side effects of the medications or treatments being studied – Unwanted events during the trial that may or may not be related to the study drug – Failure of a treatment to work

The research team will continuously monitor your or your child’s health and safety throughout the trial, whether you are receiving the drug being studied or a placebo. Remember: You can leave a study at any time. Those who are monitoring the trial for safety — such as the principal investigator can pull your child from a study if they believe their health is declining.

People with Rett Syndrome and their families who take part in clinical trials are pioneers. They are helping to beat a path to better treatments for Rett for all of us. Register your child or adult with Rett today so that you can stay informed as and when opportunities to participate become available.

It’s a big decision to take part in a clinical trial for any reason, particularly when the trial centre is hundreds of miles from your home. Professor Santosh and the team have understood the logistical impact of every visit we make to King’s, and Emily’s well-being has been paramount at every step of the journey, which is very reassuring. The practical assistance from the Reverse Rett team to make sure accommodation is booked and appropriate to our needs, takes much of the stress out of the process. We knew there were no guarantees when we started the trial. Emily has been committed to this trial from the start, despite the travel, inconvenience and occasional discomfort caused by taking part. I think this shows just how much Emily values a treatment for her breath-holding and hyperventilation. It’s exciting to be part of a breakthrough in treating one of the distressing symptoms of Rett Syndrome.

Jayne, Emily’s mum

Sign up to the Rett Registry UK and help us bring treatments for Rett syndrome home

Signing up means we can contact you directly about clinical trials, the latest research and enables us to make a better case for improved clinical provision and better treatments to become available in the UK.

Hospital Passport: Making trips to the hospital a little less stressful.

Hospital visits can be an ordeal for children and adults with Rett and their families. As much as possible, children and adults with Rett syndrome should be accompanied at all times with a caregiver who can advocate for their needs and who knows them well enough to know what’s ‘normal’ for them and when they are in pain. If this is not possible, a hospital passport can help support effective care and management for someone with Rett in your absence.

Staying healthy with Rett Syndrome.

Here you can find resources which can help you keep someone with Rett syndrome as healthy as possible until treatments are approved.

Latest news

  • Charities urged to check fundraisers’ credentials due to Pudsey scammer

    Charities urged to check fundraisers’ credentials due to Pudsey scammer

    Charities have been in the news this week, due to the unscrupulous acts of
  • Taysha receives go-ahead for early dose escalation in adolescent and adult Rett syndrome gene therapy trial 

    Taysha receives go-ahead for early dose escalation in adolescent and adult Rett syndrome gene therapy trial 

    Yesterday, 19th March 2024, Taysha Gene Therapies published a press release with an update
  • Scoliosis in Rett syndrome: Repeat cancellations of essential operations in UK as a safeguarding concern.

    Scoliosis in Rett syndrome: Repeat cancellations of essential operations in UK as a safeguarding concern.

    This article may be a difficult read for young or newly diagnosed families but